(424 days)
No
The summary describes a standard I.V. administration set and its compatibility with infusion pumps. There is no mention of AI or ML in the device description, intended use, or performance studies.
Yes.
The device is used for the infusion of parenteral fluids and medications into a patient's vascular system, which is a therapeutic intervention.
No
This device is an I.V. administration set, described as a tool for infusing parenteral fluids and medications into a patient's vascular system. Its function is to deliver substances, not to diagnose conditions.
No
The device description explicitly lists physical components such as a spike, drip chamber, roller clamp, tubing, etc., indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the infusion of fluids and medications into a patient's vascular system. This is a direct interaction with the patient's body for therapeutic purposes.
- Device Description: The description details components for delivering fluids intravenously, such as a spike, drip chamber, tubing, and luer lock. These are all components of a system for administering substances to a patient.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. IVDs typically involve analyzing blood, urine, tissue, etc.
Therefore, this device falls under the category of a medical device used for treatment/administration, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
I.V. Administration Set for the infusion of parenteral fluids and medications from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only.
Product codes
FPA
Device Description
The Volumat Polyethylene I.V. Administration Sets (PE Sets) are available for dedicated use with the Agilia Infusion Pump and the Agilia VP MC Pump, or they can administer parenteral fluids and medications by gravity flow. Both the Agilia Infusion Pump and the Volumat I.V. Administration Sets were cleared under K121613. The Agilia VP MC Pump was cleared under K210073. The PE Sets include a spike, drip chamber, roller clamp, upstream/downstream clamp, backcheck valve, pump segment, needle-free port, rotating male luer lock, and tubing.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
patient's vascular system
Indicated Patient Age Range
Adults and Pediatrics Patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Functional performance bench testing was conducted to demonstrate that the Volumat Polyethylene I.V. Administration Set performs as intended. The performance testing included:
- ISO 8536-8 (Leakage, Tensile Strength, Storage Tube Volume)
- ISO 80369-20 (Luer Fittings: Stress Cracking, Resistance to Separation from Axial Loading, Resistance to Separation from Unscrewing, Resistance to Overriding)
- ISO 8536-4 (Closure-piercing Device Testing, Air-inlet Device Testing, Tubing Testing, Flow Requirements of the Infusion Pump, Drip Chamber Testing, Clamp Opening and Closing, Protective Cap Testing, Chemical Compatibility Testing)
- ISO 8536-14 (Clamps and Flow Regulators Testing)
- ISO 11607-1 & 2 and ASTM D4169 (Sterile Barrier and Packaging Systems and Simulated Shipping)
- Particulate USP Particulate Matter in Injections (Particulate Testing)
- Pump Segment Compatibility Testing with Infusion Pump
- Operation under Temperature, Pressure and Humidity
- Microbial Ingress Testing
- Usability Testing
Biocompatibility tests successfully conducted on the Volumat Polyethylene I.V. Administration Set included: Acute Systemic Toxicity, Hemolysis, Irritation, Sensitization, Cytotoxicity, Pyrogens, Subacute/subchronic toxicity.
No clinical testing was performed.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the seal of the Department of Health & Human Services. To the right of the seal is the FDA logo in blue, with the words "U.S. FOOD & DRUG" on one line and "ADMINISTRATION" on the line below. The logo is simple and professional, and it is easily recognizable.
June 16, 2023
Fresenius Kabi % Jason Ma Sr. Manager, Regulatory Affairs Fresenius Kabi USA,LLC 3 Corporate Dr Suite 300 Lake Zurich, Illinois 60047
Re: K221121
Trade/Device Name: Volumat Polyethylene I.V. Administration Set Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: Class II Product Code: FPA Dated: May 18, 2023 Received: May 18, 2023
Dear Jason Ma:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Porsche Bennett
For David Wolloscheck, Ph.D. Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices. and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K221121
Device Name
Volumat Polyethylene I.V. Administration Set
Indications for Use (Describe)
I.V. Administration Set for the infusion of parenteral fluids and medications from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only.
Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue wavy lines on the left and the words "FRESENIUS KABI" in blue on the right. The word "FRESENIUS" is on top of the word "KABI".
Fresenius Kabi Three Corporate Drive
Lake Zurich, Illinois 60047
T 847-550-2300
T 847-550-2300
T 888-391-6300 www.fresenius-kabi.us
510(k) SUMMARY- K221121
| 1. Date Prepared: | June 16, 2023 |
|---|---|
| 2. Submitter Information | |
| Name: | Fresenius Kabi |
| Address: | Fresenius Kabi AG |
| 61346 Bad Homburg | |
| Germany | |
| Contact Person: | Jason Ma |
| Sr. Manager, Regulatory Affairs | |
| Fresenius Kabi USA, LLC | |
| Three Corporate Drive, 2nd Floor | |
| Lake Zurich, IL 60047 USA | |
| Phone: 224-817-4100 | |
| Fax: 847 550 2960 | |
| E-mail: Jason.ma01@fresenius-kabi.com | |
| Secondary Contact Person: | Keith Dunn |
| Director, Regulatory Affairs | |
| Fresenius Kabi USA, LLC | |
| Three Corporate Drive, 2nd Floor | |
| Lake Zurich, IL 60047 USA | |
| Phone: 224-817-2430 | |
| Fax: 847 550 2960 | |
| E-mail: Keith.Dunn@fresenius-kabi.com |
3. Device Name and Classification
| Device Trade Name: | Volumat Polyethylene I.V. Administration Set |
|---|---|
| Common Name: | I.V. Administration Set |
| Classification Name: | Intravascular administration set |
| Regulation Number | 21 CFR 880.5440 |
| Regulatory Class: | Class II |
| Product Code: | FPA |
4
Image /page/4/Picture/0 description: The image contains the logo for Fresenius Kabi. The logo consists of three blue, wavy lines on the left side. To the right of the lines, the words "FRESENIUS" and "KABI" are stacked on top of each other, also in blue. The logo is simple and modern, with a focus on the company name.
hree Cornorate Drive ke Zurich, Illinois 60047 847-550-2300 888-391-6300 ww.fresenius-kabi.us
4. Predicate Device
| Device Trade Name: | Intravascular Administration Sets |
|---|---|
| Common Name: | Intravascular Administration Set |
| Classification Name: | 21 CFR 880.5440 |
| Regulatory Class: | Class II |
| Product Code: | FPA |
| 510(k) Number: | K203609 |
5. Device Description
The Volumat Polyethylene I.V. Administration Sets (PE Sets) are available for dedicated use with the Agilia Infusion Pump and the Agilia VP MC Pump, or they can administer parenteral fluids and medications by gravity flow. Both the Agilia Infusion Pump and the Volumat I.V. Administration Sets were cleared under K121613. The Agilia VP MC Pump was cleared under K210073. The PE Sets include a spike, drip chamber, roller clamp, upstream/downstream clamp, backcheck valve, pump segment, needle-free port, rotating male luer lock, and tubing.
| Set Number | Description |
|---|---|
| M46441395 | Volumat Polyethylene I.V. Administration Set with spike, air vent, drip chamber, roller clamp, pump segment, rotating male luer |
| M46441995 | Volumat Polyethylene I.V. Administration Set with spike, air vent, drip chamber, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer |
| M46444495 | Volumat Polyethylene I.V. Administration Set with spike, air vent, drip chamber, upstream clamp, backcheck valve, upstream needle-free port, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer |
| M46445495 | Volumat Polyethylene I.V. Administration Set with spike, air vent, drip chamber, upstream clamp, backcheck valve, upstream needle-free port, roller clamp, pump segment, downstream clamp, downstream needle-free port, rotating male luer |
6. Principle of Operation
The range of sets provides options for intermittent or continuous delivery of parenteral fluids (solutions, colloids, parenteral nutrition) and medications (including but not limited to diluted drugs, chemotherapy) through clinically accepted intravenous (I.V.) routes of administration.
The device may be used for Adults and Pediatrics Patients.
7. Indication for Use/ Intended Use
5
Image /page/5/Picture/0 description: The image features the logo of Fresenius Kabi, a global healthcare company. On the left side of the logo, there are three stylized, vertical blue lines that resemble waves or abstract shapes. To the right of these lines, the words "FRESENIUS" and "KABI" are stacked on top of each other in a bold, sans-serif blue font. The overall design is clean and corporate, conveying a sense of stability and innovation.
w.fresenius-kabi.us
Indication for Use:
I.V. Administration Set for the infusion of parenteral fluids and medications from a container into the patient's vascular system through a vascular access device with Agilia VP MC/Volumat MC Agilia pump or gravity only.
Intended Use:
Volumat Polyethylene I.V. Administration Sets are intended for the administration of drugs and solutions.
8. Comparison of the Technological Characteristics with the Predicate Device
The technological characteristics of the subject device are substantially equivalent to those of the predicate device in regard to the following technological characteristics:
- . Principle of operation and conditions of use of the subject device are the same as those of the predicate device.
- Materials of the proposed device do not raise new questions of safety and . effectiveness, as demonstrated by performance testing and biocompatibility evaluation.
- . Physical specifications of the subject device are equivalent to those of the predicate device.
A comparison between the predicate device and the subject device is provided in Table 1 and Table 2 below.
| Technological
Characteristics | Volumat Polyethylene
I.V. Administration
Sets (Subject Device) | Baxter Administration
Set K203609
(Predicate Device) | Assessment of
Differences |
|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indication for Use | IV Administration set
for the infusion of
parenteral fluids and
medications from a
container into the
patient's vascular
system through a
vascular access device
with Agilia VP MC
pumps/Volumat MC
Agilia pump or gravity
only. | For the administration of
fluids from a container
into the patients'
vascular system through
a vascular access device. | Similar. Both I.V.
administration sets are
used to administer fluids
from a container to a
patient. However, the
Subject Device
interoperates with
infusion systems that
have been cleared in
other 510(k) submissions
including K121613 and
K210073.. |
| Operating
Mechanism | The Volumat
administration sets
deliver the intravenous | The Baxter
administration sets can
be used to deliver | Similar, both devices can
be used with an infusion
pump or by gravity flow. |
| Technological
Characteristics | Volumat Polyethylene
I.V. Administration
Sets (Subject Device) | Baxter Administration
Set K203609
(Predicate Device) | Assessment of
Differences |
| | infusions via an infusion
pump through a
pumping mechanism
("cassette") or by
gravity flow. | solutions for gravity or
pump by infusion of I.V.
fluids. | The predicate device
does not have a pumping
mechanism ("cassette").
Difference has been
verified through
performance testing
including flow rate
accuracy under various
environmental conditions
(temperature, pressure,
humidity) which
demonstrate equivalence. |
| Sterile | Yes | Yes | Same |
| Non-Pyrogenic | Yes | Yes | Same |
| Single Use | Yes | Yes | Same |
| Length | 75-105 inches | 69-133.5 inches | Similar. The sets
included in the subject
device range in length
from 75 inches to 105
inches which is within
the range of the predicate
device.
Difference tested
according to ISO 8536-4
and flow rate accuracy to
demonstrate the subject
device performance. |
| Priming Volume | 21-27 ml | 6.1 to 21.2 mL | Similar. The Volumat set
requires more priming
volume than the
predicate. Bench testing
confirmed that the
differences in priming
volume do not impact
safety or effectiveness. |
| Internal Tube
Diameter | 0.122 inches | 0.102 to 133 inches | Similar internal and
external diameter and
approximate range of the
predicate device.
Difference tested to ISO
8536-8 has demonstrated
equivalence. |
| External Tube
Diameter | 0.164 inches | 0.140-0.209 inches | |
| Components | | | |
| Spike | Yes | Yes | Different. The subject
device includes an |
| Drip chamber | Yes | Yes | |
| Technological
Characteristics | Volumat Polyethylene
I.V. Administration
Sets (Subject Device) | Baxter Administration
Set K203609
(Predicate Device) | Assessment of
Differences |
| Backcheck Valve | Yes | Yes | additional pumping |
| Pump Segment | Yes | No | segment. However, no |
| Needle Free Port | Yes | Yes | significant difference |
| Male Luer | Yes | Yes | between the subject and |
| Roller Clamp | Yes | Yes | predicate administration |
| Connector Luer
Lock | Yes | Yes | sets that would raise new
issues of safety or
efficacy.
The differences have
been verified in various
aspects to demonstrate
the subject device's
safety and performance
including:
Biocompatibility testing
according to ISO 10993
collateral standards,
Microbial Ingress
Testing, and Particulate
Testing; Performance
Testing according to ISO
8536-4, ISO 80369-20,
ISO 8536-8 and ISO
8436-14. |
Table 1: Summary of Substantial Equivalence Comparison
6
Image /page/6/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of a blue abstract symbol on the left and the words "FRESENIUS KABI" in blue on the right. The abstract symbol is made up of three curved lines.
Fresenius Kabi
Fresemius Kabi
Thresemius Italia Drive
Lake Zurion atabile Drive
Lake Zurion 223000
T 888-3991-233000
www.fresenius-kabil.us
7
Image /page/7/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue, wavy lines on the left side. To the right of the lines, the words "FRESENIUS" and "KABI" are written in blue, with "FRESENIUS" on top of "KABI".
Fresenius Kabi
Theo Corporation Drive
Lake Zunich, Illinois 60047
Take Zunich, Illinois 60047
Trad47-5550-2300
www.fresenius-kabi.us
Table 2: Summary of Material Comparison
| Component | Modified Volumat I.V.
Administration Set
(Subject Device) | Baxter
Administration Set
K203609
(Predicate Device) | Assessment of Differences |
|-----------------|-----------------------------------------------------------------|---------------------------------------------------------------|----------------------------------------------------------------------------------------------------|
| Spike | Polystyrene | Acrylonitrile
Butadiene Styrene | Similar, testing to
biocompatibility and
performance standards
demonstrated equivalence |
| Drip chamber | Polystyrene, styrene-
butadiene-copolymer,
Polyamide | Polyvinyl Chloride | Different, testing to
biocompatibility and
performance standards
demonstrated equivalence |
| Backcheck Valve | Methylmethacrylate-
Acrylonitrile-Butadiene-
Styrene) | Polymethyl
methacrylate (acrylic)
Silicone Rubber | Similar, testing to
biocompatibility and
performance standards
demonstrated equivalence |
| Pump Segment | Methylmethacrylate-
Acrylonitrile-Butadiene-
Styrene | N/A – predicate
device does not have
a pump segment | Testing to biocompatibility
and performance standards
demonstrated equivalence |
8
Image /page/8/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue, curved lines on the left side. To the right of the lines, the words "FRESENIUS" and "KABI" are written in blue, with "FRESENIUS" on top of "KABI".
888-391-6300 ww.fresenius-kabi.us
| Component | Modified Volumat I.V.
Administration Set
(Subject Device) | Baxter
Administration Set
K203609
(Predicate Device) | Assessment of Differences |
|----------------------------|-------------------------------------------------------------------------|---------------------------------------------------------------|--------------------------------------------------------------------------------------------------|
| Needle Free Port | Methylmethacrylate-
Acrylonitrile-Butadiene-
Styrene, Copolyester | Polyester | Similar, Testing to
biocompatibility and
performance standards
demonstrated equivalence |
| Rotating Male Luer
Lock | Polyvinylchloride,
Acrylonitrile butadiene
styrene | Acrylonitrile
butadiene styrene | Similar, Testing to
biocompatibility and
performance standards
demonstrated equivalence |
| Tubing | Polyvinyl chloride,
ethylene-vinyl acetate,
polyethylene | Polyvinyl chloride | Similar, Testing to
biocompatibility and
performance standards
demonstrated equivalence |
9. Substantial Equivalence
Intended Use/Indication for Use-Discussion of Differences
Both the subject and predicate device have the same intended use and similar indication for use. Both I.V. administration sets are used to administer fluids.
Technological Characteristics—Discussion of Differences
- Both the subject and predicate device can be used with an infusion pump or by gravity flow. The subject device delivers the intravenous infusions via an infusion pump through a pumping mechanism ("cassette") or by gravity flow, and the predicate device does not have a pumping mechanism ("cassette").
- The subject device ranges in length from 75 inches to 105 inches, which is within . the length range of the predicate device.
- . The subject device carries more priming volume than the predicate. Bench testing confirmed that the differences in priming volume do not impact safety or effectiveness.
- . The subject device includes an additional pumping segment. However, no significant difference between the subject and predicate administration sets that would raise new issues of safety or efficacy.
Conclusion on Substantial Equivalence
9
Image /page/9/Picture/0 description: The image contains the logo for Fresenius Kabi. On the left side of the logo are three blue, vertical, wavy lines. To the right of the lines is the text "FRESENIUS KABI" in blue, with "FRESENIUS" on top of "KABI".
ee Cornorate Drive Zurich, Illinois 60047 888-391-6300 ww.fresenius-kabi.us
The Volumat Polyethylene I.V. Administration Set has the same intended use and equivalent indication for use as the predicate device. The subject device has similar technological characteristics to the predicate, and the descriptive and performance information provided within this premarket notification demonstrates that:
- any differences do not raise different questions of safety and . effectiveness compared to the predicate device; and
- . the proposed device is at least as safe and effective as the legally marketed predicate device.
Based on the comparison of the intended use and the technological characteristics, the subject device is substantially equivalent to the currently marketed predicate device.
10.Performance Testing
Performance Testing-Bench
Functional performance bench testing was conducted to demonstrate that the Volumat Polyethylene I.V. Administration Set performs as intended.
The following performance testing was conducted to support the substantial equivalence determination:
- ISO 8536-8 .
- o Leakage
- o Tensile Strength
- o Storage Tube Volume
- ISO 80369-20 ●
- o Luer Fittings
- Stress Cracking о
- Resistance to Separation from Axial Loading o
- Resistance to Separation from Unscrewing O
- o Resistance to Overriding
- ISO 8536-4 ●
- o Closure-piercing Device Testing
- Air-inlet Device Testing о
- Tubing Testing O
- Flow Requirements of the Infusion Pump O
- Drip Chamber Testing O
- Clamp Opening and Closing O
- Protective Cap Testing о
- Chemical Compatibility Testing O
10
Image /page/10/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of a blue abstract symbol on the left and the words "FRESENIUS KABI" in blue on the right. The abstract symbol is made up of three curved lines that are parallel to each other.
w.fresenius-kabi.us
- ISO 8536-14 ●
- 0 Clamps and Flow Regulators Testing
- ISO 11607-1 & 2 and ASTM D4169 ● O Sterile Barrier and Packaging Systems and Simulated Shipping
- Particulate USP Particulate Matter in Injections ●
- o Particulate Testing
- Pump Segment Compatibility Testing with Infusion Pump
- Operation under Temperature, Pressure and Humidity
- Microbial Ingress Testing ●
- . Usability Testing
11.Biocompatibility Testing
Following the FDA Guidance: "Use of International Standard ISO 10993-1, Biological evaluation of medical devices-Part 1: Evaluation and testing within a risk management process", the tests selected were for prolonged, blood path indirect, externally communicating devices. The following biocompatibility tests were successfully conducted on the Volumat Polyethylene I.V. Administration Set:
- Acute Systemic Toxicity
- Hemolysis ●
- Irritation ●
- Sensitization ●
- Cytotoxicity ●
- Pyrogens ●
- Subacute/subchronic toxicity ●
12. Sterilization Validation
Sterilization was achieved by ethylene oxide and meets the requirements of DIN EN ISO 11135:2020, which is equivalent to ISO 11135 (2014-7) + AMD 1 (2018-10). The ethylene oxide sterilization method achieves a Sterilization Assurance Level (SAL) of 10-6.
13. Clinical Testing
No clinical testing was performed as this device does not require clinical studies to demonstrate substantial equivalence with the predicate device.
11
Image /page/11/Picture/0 description: The image shows the Fresenius Kabi logo. The logo consists of three blue wavy lines on the left and the words "FRESENIUS KABI" in blue on the right. The word "FRESENIUS" is on top of the word "KABI".
Fresenius Kabi Three Corporate Drive Lake Zurich, Illinois 60047 T 847-550-2300 T 888-391-6300 www.fresenius-kabi.us
14. Conclusion
The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. The subject device, Volumat Polyethylene I.V. Administration Set is substantially equivalent to the predicate device, I.V. Administration Set, cleared under K203609.